Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Tumour microenvironment and circulating biomarkers predict response to...

Dr David Braun - Yale School of Medicine, New Haven, USA

Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )

ctDNA-guided chemo escalation does not improve recurrence-free survival in...

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )

Disparities in mammogram screening amongst LGBTQ+ populations

Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA

Disparities in mammogram screening amongst LGBTQ+ populations ( Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA )

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers

Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil

AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancers ( Dr Marina De Brot - A.C. Camargo Cancer Center, São Paulo, Brazil )

Barriers to global oncology clinical trial participation in sub-Saharan Africa

Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA

Barriers to global oncology clinical trial participation in sub-Saharan Africa ( Dr Oyepeju Folashade Abioye - Allegheny Health Network, Pittsburgh, USA )

Social determinants and survival outcomes in early-onset colorectal cancer in...

Dr Jessica Paulus - Ontada, Boston, USA

Social determinants and survival outcomes in early-onset colorectal cancer in the US ( Dr Jessica Paulus - Ontada, Boston, USA )

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers...

Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora...

Low frequency of dihydropyrimidine dehydrogenase variants in Mexican GI cancers should induce testing guideline reform ( Dr Enrique Soto Pérez de Celis - University of Colorado Cancer Center, Aurora, USA )

Molecular assay may help identify NSCLC patients who could benefit from...

Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy ( Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA )

ASCO 2025: Update on blood-based cancer assays

Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA

ASCO 2025: Update on blood-based cancer assays ( Dr Marie Wood - UCHealth University of Colorado Hospital, Aurora, USA )

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables...

Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA

HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testing ( Dr Nadine M Tung - Beth Israel Deaconess Medical Center, Boston, USA )

Ecological evaluation of climate risks for cancer survivors

Dr Joseph Unger - Fred Hutchinson Cancer Center, Seattle, USA

Ecological evaluation of climate risks for cancer survivors ( Dr Joseph Unger - Fred Hutchinson Cancer Center, Seattle, USA )

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received...

Prof Thomas Powles - Barts Cancer Institute, London, England

CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative durvalumab ( Prof Thomas Powles - Barts Cancer Institute, London, England )

More from ecancer